Jushi Holdings (JUSHF) Cash from Operations (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Cash from Operations came in at 8612000.0 in Q1 2026, up 14.38% year-on-year from 7529000.0 in Q1 2025, and up 42.32% on a QoQ basis from 6051000.0 in Q4 2025.
Jushi Holdings (JUSHF) Cash from Operations (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Cash from Operations data on file, last reported at 8612000.0 in Q1 2026.
- On a quarterly basis, Cash from Operations rose 14.38% year-over-year to 8612000.0 in Q1 2026; TTM through Mar 2026 was 18808000.0, a 16.8% decrease from a year earlier, with the FY2025 full-year figure at 17725000.0, down 17.82% from the prior year.
- Cash from Operations for Q1 2026 stood at 8612000.0, up from 6051000.0 in the prior quarter.
- Over the last five years, Cash from Operations for JUSHF reached as high as 8612000.0 in Q1 2026 and fell as low as 13825000.0 in Q1 2022.
- Historically, Cash from Operations has averaged 1363058.82 across 5 years, with a median of 4509000.0 in 2023.
- Across the five-year window, Cash from Operations jumped 603.69% in 2023 and plunged 134.88% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 4783000.0 in 2022, then decreased by 5.73% to 4509000.0 in 2023, then surged by 58.66% to 7154000.0 in 2024, then retreated by 15.42% to 6051000.0 in 2025, then jumped by 42.32% to 8612000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were 8612000.0 in Q1 2026, 6051000.0 in Q4 2025, and 6080000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | 8.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.61 Mn |
| Mar 31, 2026 | 8.61 Mn |
| Dec 31, 2025 | 6.05 Mn |
| Dec 31, 2025 | 6.05 Mn |
| Sep 30, 2025 | 6.08 Mn |
| Sep 30, 2025 | 6.08 Mn |
| Jun 30, 2025 | -1.94 Mn |
| Jun 30, 2025 | -1.94 Mn |
| Mar 31, 2025 | 7.53 Mn |
| Mar 31, 2025 | 7.53 Mn |
| Dec 31, 2024 | 7.15 Mn |
| Dec 31, 2024 | 7.15 Mn |
| Sep 30, 2024 | 2.37 Mn |
| Sep 30, 2024 | 2.37 Mn |
| Jun 30, 2024 | 5.55 Mn |
| Jun 30, 2024 | 5.55 Mn |
| Mar 31, 2024 | 6.49 Mn |
| Mar 31, 2024 | 6.49 Mn |
| Dec 31, 2023 | 4.51 Mn |
| Dec 31, 2023 | 4.51 Mn |